Rapid identification of reactive cysteine residues for site-specific labeling of antibody-Fabs.
暂无分享,去创建一个
R. Scheller | C. Eigenbrot | H. Lowman | S. Bhakta | J. R. Junutula | R. Vandlen | Jagath R Junutula | Jagath R. Junutula | H. Raab | Karen E. Ervin
[1] P. Klatt,et al. Regulation of protein function by S-glutathiolation in response to oxidative and nitrosative stress. , 2000, European journal of biochemistry.
[2] Y. Xu,et al. Oxidation of zinc-binding cysteine residues in transcription factor proteins. , 2001, Antioxidants & redox signaling.
[3] L. Presta,et al. Antibody Humanization Using Monovalent Phage Display* , 1997, The Journal of Biological Chemistry.
[4] C. Barbas,et al. Direct selection for a catalytic mechanism from combinatorial antibody libraries. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[5] L. Presta,et al. X-ray structures of the antigen-binding domains from three variants of humanized anti-p185HER2 antibody 4D5 and comparison with molecular modeling. , 1993, Journal of molecular biology.
[6] P M van Wezenbeek,et al. Nucleotide sequence of the filamentous bacteriophage M13 DNA genome: comparison with phage fd. , 1980, Gene.
[7] Núria Romero-Isart,et al. Advances in the structure and chemistry of metallothioneins. , 2002, Journal of inorganic biochemistry.
[8] Damon L. Meyer,et al. Effects of Drug Loading on the Antitumor Activity of a Monoclonal Antibody Drug Conjugate , 2004, Clinical Cancer Research.
[9] C. Anfinsen. Principles that govern the folding of protein chains. , 1973, Science.
[10] P. Carter,et al. Sequence plasticity in the antigen-binding site of a therapeutic anti-HER2 antibody. , 2002, Journal of molecular biology.
[11] S. Carroll,et al. Cysteine analogs of recombinant barley ribosome inactivating protein form antibody conjugates with enhanced stability and potency in vitro. , 1994, Bioconjugate chemistry.
[12] L. Presta,et al. Antigen binding thermodynamics and antiproliferative effects of chimeric and humanized anti-p185HER2 antibody Fab fragments. , 1992, Biochemistry.
[13] S. Wootton,et al. Homo-Oligomerization of the Porcine Reproductive and Respiratory Syndrome Virus Nucleocapsid Protein and the Role of Disulfide Linkages , 2003, Journal of Virology.
[14] L. Presta,et al. Humanization of an anti-p185HER2 antibody for human cancer therapy. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[15] S. Betz. Disulfide bonds and the stability of globular proteins , 1993, Protein science : a publication of the Protein Society.
[16] Damon L. Meyer,et al. Enhanced activity of monomethylauristatin F through monoclonal antibody delivery: effects of linker technology on efficacy and toxicity. , 2006, Bioconjugate chemistry.
[17] M Aizawa,et al. Assembling of engineered IgG-binding protein on gold surface for highly oriented antibody immobilization. , 2000, Journal of biotechnology.
[18] P G Schultz,et al. A method for directed evolution and functional cloning of enzymes. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[19] J. Sambrook,et al. Molecular Cloning: A Laboratory Manual , 2001 .
[20] R. Feeney,et al. Chemical modifications of proteins: history and applications. , 1990, Bioconjugate chemistry.
[21] T. Clackson,et al. In vitro selection from protein and peptide libraries. , 1994, Trends in biotechnology.
[22] S. Sidhu,et al. Bivalent antibody phage display mimics natural immunoglobulin. , 2004, Journal of immunological methods.
[23] D. Powers,et al. In vivo formation and stability of engineered disulfide bonds in subtilisin. , 1986, The Journal of biological chemistry.
[24] Min Zhang,et al. Albumin Binding as a General Strategy for Improving the Pharmacokinetics of Proteins* , 2002, The Journal of Biological Chemistry.
[25] A. Glazer. Specific chemical modification of proteins. , 1970, Annual review of biochemistry.
[26] B. Matthews,et al. Use of site-directed mutagenesis to obtain isomorphous heavy-atom derivatives for protein crystallography: cysteine-containing mutants of phage T4 lysozyme. , 1987, Protein engineering.
[27] J. Marks,et al. Toward selection of internalizing antibodies from phage libraries. , 1999, Biochemical and biophysical research communications.
[28] R. Scheller,et al. Rab14 is involved in membrane trafficking between the Golgi complex and endosomes. , 2004, Molecular biology of the cell.
[29] J. Gutteridge,et al. Thiols in cellular redox signalling and control. , 2001, Current medicinal chemistry.
[30] R. Kelley,et al. FAB Assembly and Enrichment in a Monovalent Phage Display System , 1991, Bio/Technology.
[31] Phage display of peptide libraries on protein scaffolds. , 1998, Methods in molecular biology.
[32] Sachdev S Sidhu,et al. Exploring Protein–Protein Interactions with Phage Display , 2003, Chembiochem : a European journal of chemical biology.
[33] I. Cotgreave,et al. Recent trends in glutathione biochemistry--glutathione-protein interactions: a molecular link between oxidative stress and cell proliferation? , 1998, Biochemical and biophysical research communications.
[34] A. Kung,et al. Gelonin analogs with engineered cysteine residues form antibody immunoconjugates with unique properties. , 1994, The Journal of biological chemistry.
[35] A. Mercurio,et al. Carbohydrate-binding protein 35 (Mac-2), a laminin-binding lectin, forms functional dimers using cysteine 186. , 1991, The Journal of biological chemistry.